AuntMinnie

JANUARY 26, 2024

In a comparative imaging trial, fibroblast activation protein inhibitor (FAPI)-PET/CT outperformed FDG-PET/CT in detecting primary tumors in patients with head and neck cancer, according to a study published January 25 in the Journal of Nuclear Medicine. PET/CT and MR images of a 72-year-old woman. (A)

Nuclear Medicine 122

Nuclear Medicine Imaging MRI Diagnostic 122

AuntMinnie

APRIL 4, 2024

Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. They're also mindful of the multiple dedicated teams required to build a theranostics clinic properly.

Nuclear Medicine 88

Nuclear Medicine Radiation Oncology Nursing Radiation 88

Imaging Technology

JULY 26, 2023

milla1cf Wed, 07/26/2023 - 20:36 July 26, 2023 — A molecular imaging tool developed by researchers at the University of California’s two nationally ranked medical centers, UCLA and UCSF , helps improve the accuracy of predicting the risk of cancer recurrence in patients with intermediate to high-risk prostate cancer who undergo surgery.

Nuclear Medicine 97

Nuclear Medicine Imaging Disease Clinic 97

Imaging Technology

JUNE 29, 2023

christine.book Thu, 06/29/2023 - 12:17 June 29, 2023 — A study presented this week during the 2023 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, SNMMI 2023 , found that personalized dosing of men with prostate cancer resulted in improved patient outcomes. Approved by the U.S. Patients at St.

Nuclear Medicine 98

Nuclear Medicine Hospital Disease Clinic 98

Imaging Technology

MAY 31, 2023

milla1cf Wed, 05/31/2023 - 20:52 May 31, 2023 — GE HealthCare announced US FDA 510(k) clearance of Precision DL – a new, revolutionary deep learning-based image processing software included in GE HealthCare’s growing Effortless Recon DL portfolio. Gallen in Switzerland [vii].

Nuclear Medicine 98

Nuclear Medicine Healthcare Healthcare IT 98

AuntMinnie

JUNE 20, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

Imaging Technology

OCTOBER 4, 2024

Theranostics represents a more personalized form a medicine – one which treats each patient as an individual, recognizing that the same treatment plan and dose doesn’t work for everyone, all with the goal of providing more effective medical care. 2022 Oct;63(10):1467-1474. Dosimetry in Radiopharmaceutical Therapy. J Nucl Med.

Radiopharmaceuticals 52

Radiopharmaceuticals Nuclear Medicine Radiation Healthcare 52

AuntMinnie

JUNE 3, 2024

Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology.

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 105

Imaging Technology

JUNE 28, 2023

milla1cf Wed, 06/28/2023 - 20:28 June 28, 2023 — GE HealthCare is set to unveil SIGNA PET/MR AIR [i] , at the Society of Nuclear Medicine and Molecular Imaging ( SNMMI) 2023 annual meeting. The recent approval of drugs with disease modifying potential require additional imaging of patients with both MR and PET.

Healthcare 98

Healthcare Healthcare Disease Nuclear Medicine 98

Imaging Technology

APRIL 3, 2023

produced, non-uranium based Mo-99 for use in diagnostic imaging. These capabilities will help them develop and deliver products with the potential to improve care for even more patients with serious disease. “In In parallel with these initiatives, NorthStar’s imaging portfolio continues to advance,” Mr. Merrick further added.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

AuntMinnie

APRIL 15, 2024

FAPI-PET imaging could emerge as a new tool for assessing patients with single pulmonary tumors, especially in those with negative results on other scans, according to a study published April 11 in the Journal of Nuclear Medicine. FAPI-PET either confirmed or ruled out the disease in all cases, the group found.

Nuclear Medicine 122

Nuclear Medicine PET Scan Hospital Clinic 122

Imaging Technology

JUNE 19, 2023

milla1cf Mon, 06/19/2023 - 19:27 June 19, 2023 — NorthStar Medical Technologies, LLC , a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced the appointment of Frank Scholz, Ph.D., NorthStar’s commercialized, U.S.-based

Medical 98

Medical Pharmaceutical Radiopharmaceuticals Nuclear Medicine 98